As research continues into how AI will impact practice, there are open questions about medical training, regulation, and more ...
Morning Overview on MSN
A new ‘autopilot’ medical device could speed heart attack recovery
Heart attack care is entering a phase where machines do not just assist doctors, they anticipate the next move. A new ...
Study Finds on MSN
Financial Stress Linked To Heart Aging As Strongly As Major Medical Conditions, AI Study Finds
Money troubles associated with 60% higher death risk in study using AI to measure heart aging. Financial strain topped nine ...
Researchers sought to determine the ability of a validated ECG-based AI model for AF risk prediction to determine future incidence of HF and stroke.
News-Medical.Net on MSN
Financial strain and food insecurity drive accelerated cardiac aging
A novel analysis investigating the contribution of social determinants of health (SDoH) to cardiac aging has found that ...
Deepak Ambudkar founded Energeiaa at 50, creating a wellness assessment tool that quantifies health using non-invasive technology and AI insights.
Version 1.1 Designed to Provide Best Usability of any ECG SystemSouthlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a ...
TipRanks on MSN
TrivarX achieves breakthrough in veteran mental health diagnostics with single-lead ECG success
An update from TrivarX Limited ( ($AU:TRI) ) is now available. TrivarX Limited reported positive results from a clinical trial evaluating its ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...
Tempus has a projected earnings growth rate of 58.9% for 2025, higher than the industry’s 37% growth. The company has a favorable current cashflow rate of 267.2% against the industry’s 28.3%. TEM has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results